Cost and Quality

Latest California Healthline Stories

KHN’s ‘What The Health?’: We Answer Your Questions

You asked about drug prices, the “Cadillac tax” on generous insurance plans and why Americans don’t know that most other countries also have combination public-private insurance systems. This week, Anna Edney of Bloomberg News, Alice Miranda Ollstein of Politico and Caitlin Owens of Axios join KHN’s Julie Rovner to answer those questions.

Despite Failed Promises, Stem Cell Advocates Again Want Taxpayers To Pony Up Billions

California’s stem cell agency, created by a $3 billion bond measure 15 years ago, is almost out of money. Its supporters plan to ask voters for even more funding next year, even though no agency-funded treatments have been approved for widespread use.

Going Down Fighting: Dying Activist Champions ‘Medicare For All’

Presidential hopeful Elizabeth Warren tried to tell the story of Ady Barkan in the latest Democratic debate. He’s one of the most prominent advocates for “Medicare for All” and is spending his remaining time alive doing everything he can to make the case that all Americans need affordable health coverage.

Class-Action Lawsuit Seeks To Let Medicare Patients Appeal Gap in Nursing Home Coverage

Medicare beneficiaries under observation care in the hospital can face higher costs for treatment and are not covered for nursing home care when discharged. A federal trial in Hartford, Conn., will determine whether the government’s ban on appeals involving observation care coverage is fair.

KHN’s ‘What The Health?’: Gun Violence And The Politics Of Public Health

The recent tragic mass shootings have refocused efforts to treat gun violence as a public health issue rather than strictly a law enforcement problem. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Agnes Carey of Kaiser Health News join KHN’s Julie Rovner to discuss this, plus the health implications of the budget deal passed by Congress and signed by President Donald Trump, as well as reaction from Canada to a proposal to allow broader imports of its prescription drugs. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.

Watch: What Happened To That $500K Dialysis Bill

After journalists investigate, Fresenius, one of the largest dialysis providers in the U.S., has agreed to waive a half-million-dollar bill. Sovereign Valentine, from Plains, Mont., said it’s a “huge relief.”